{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:53:41Z","timestamp":1775210021723,"version":"3.50.1"},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:00:00Z","timestamp":1609200000000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"FIS\/FEDER","award":["PI19\/00815"],"award-info":[{"award-number":["PI19\/00815"]}]},{"name":"FIS\/FEDER","award":["DTS18\/00032"],"award-info":[{"award-number":["DTS18\/00032"]}]},{"name":"FIS\/FEDER","award":["ERA-PerMed-JTC2018"],"award-info":[{"award-number":["ERA-PerMed-JTC2018"]}]},{"name":"KIDNEY ATTACK","award":["AC18\/00064"],"award-info":[{"award-number":["AC18\/00064"]}]},{"name":"PERSTIGAN","award":["AC18\/00071"],"award-info":[{"award-number":["AC18\/00071"]}]},{"name":"PERSTIGAN","award":["ISCIII-RETIC"],"award-info":[{"award-number":["ISCIII-RETIC"]}]},{"name":"REDinREN","award":["RD016\/0009"],"award-info":[{"award-number":["RD016\/0009"]}]},{"DOI":"10.13039\/100015883","name":"Sociedad Espa\u00f1ola de Nefrolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015883","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FRIAT"},{"name":"Comunidad de Madrid en Biomedicina","award":["B2017\/BMD-3686"],"award-info":[{"award-number":["B2017\/BMD-3686"]}]},{"name":"French \u2018Plan National Maladies Rares\u2019"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The rapid spread of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has raised questions about Fabry disease (FD) as an independent risk factor for severe COVID-19 symptoms. Available real-world data on 22 patients from an international group of healthcare providers reveals that most patients with FD experience mild-to-moderate COVID-19 symptoms with an additional complication of Fabry pain crises and transient worsening of kidney function in some cases; however, two patients over the age of 55 years with renal or cardiac disease experienced critical COVID-19 complications. These outcomes support the theory that pre-existent tissue injury and inflammation may predispose patients with more advanced FD to a more severe course of COVID-19, while less advanced FD patients do not appear to be more susceptible than the general population. Given these observed risk factors, it is best to reinforce all recommended safety precautions for individuals with advanced FD. Diagnosis of FD should not preclude providing full therapeutic and organ support as needed for patients with FD and severe or critical COVID-19, although a\u00a0FD-specific safety profile review should always be conducted prior to initiating COVID-19-specific therapies. Continued specific FD therapy with enzyme replacement therapy, chaperone therapy, dialysis, renin\u2013angiotensin blockers or participation to clinical trials during the pandemic is recommended as FD progression will only increase susceptibility to infection. In order to compile outcome data and inform best practices, an international registry for patients affected by Fabry and infected by COVID-19 should be established.<\/jats:p>","DOI":"10.1093\/ckj\/sfaa227","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T20:13:56Z","timestamp":1603829636000},"page":"913-925","source":"Crossref","is-referenced-by-count":13,"title":["Fabry disease and COVID-19: international expert recommendations for management based on real-world experience"],"prefix":"10.1093","volume":"13","author":[{"given":"Dawn A","family":"Laney","sequence":"first","affiliation":[{"name":"Division of Medical Genetics, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA"}]},{"given":"Dominique P","family":"Germain","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, University of Versailles, AP-HP Paris Saclay University, Paris, France"}]},{"given":"Jo\u00e3o Paulo","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o & Faculdade de Medicina da Universidade do Porto, Porto, Portugal"}]},{"given":"Alessandro P","family":"Burlina","sequence":"additional","affiliation":[{"name":"Neurology Unit, St Bassiano Hospital, Bassano del Grappa, Italy"}]},{"given":"Gustavo Horacio","family":"Cabrera","sequence":"additional","affiliation":[{"name":"Santa Maria de la Salud, San Isidro, Provincia de Buenos Aires, Argentina"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4981-3304","authenticated-orcid":false,"given":"Geu-Ru","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yonsei University Severance Hospital, Seoul, Korea"}]},{"given":"Robert J","family":"Hopkin","sequence":"additional","affiliation":[{"name":"Division of Human Genetics, Cincinnati Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA"}]},{"given":"Dau-Ming","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan"}]},{"given":"Mark","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Royal Perth Hospital, Perth, Australia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-4811","authenticated-orcid":false,"given":"Hern\u00e1n","family":"Trimarchi","sequence":"additional","affiliation":[{"name":"Nephrology service, British Hospital, Buenos Aires, Argentina"}]},{"given":"William R","family":"Wilcox","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA"}]},{"given":"Juan Manuel","family":"Politei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fundacion Para el Estudio de Enfermedades Neurometabolicas (FESEN), Buenos Aires, Argentina"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Unidad de Dialisis, IIS-Fundacion Jimenez Diaz, School of Medicine, UAM, IRSIN and REDINREN, Madrid, Spain"}]}],"member":"286","published-online":{"date-parts":[[2020,12,24]]},"reference":[{"key":"2020122815000269200_sfaa227-B1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"2020122815000269200_sfaa227-B2","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical Fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2020122815000269200_sfaa227-B3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jmedgenet-2019-106467","article-title":"Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype\u2013phenotype workgroup","volume":"57","author":"Germain","year":"2020","journal-title":"J Med Genet"},{"key":"2020122815000269200_sfaa227-B4","year":"2020"},{"key":"2020122815000269200_sfaa227-B5","doi-asserted-by":"publisher","DOI":"10.2807%2F1560-7917.ES.2020","article-title":"Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020","volume":"25","author":"Russell","year":"2020","journal-title":"Euro Surveill"},{"key":"2020122815000269200_sfaa227-B6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-3012","article-title":"Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review","volume":"173","author":"Oran","year":"2020","journal-title":"Ann Intern Med"},{"key":"2020122815000269200_sfaa227-B7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2020122815000269200_sfaa227-B8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","article-title":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020","volume":"69","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020122815000269200_sfaa227-B9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"2020122815000269200_sfaa227-B10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.2020.4344","article-title":"Coronavirus Disease 2019 (COVID-19) in Italy","volume":"323","author":"Livingston","year":"2020","journal-title":"JAMA"},{"key":"2020122815000269200_sfaa227-B11","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"2020122815000269200_sfaa227-B12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"2020122815000269200_sfaa227-B13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"2020122815000269200_sfaa227-B14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"2020122815000269200_sfaa227-B15","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1681\/ASN.2020040419","article-title":"Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology","volume":"31","author":"Batlle","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2020122815000269200_sfaa227-B16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/01.RES.0000205761.22353.5f","article-title":"Angiotensin-converting enzyme II in the heart and the kidney","volume":"98","author":"Danilczyk","year":"2006","journal-title":"Circ Res"},{"key":"2020122815000269200_sfaa227-B17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes [published online ahead of print May 1, 2020]","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"2020122815000269200_sfaa227-B18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","article-title":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses","volume":"526","author":"Qi","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"2020122815000269200_sfaa227-B19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"key":"2020122815000269200_sfaa227-B20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1651-2227.2002.tb03112.x","article-title":"Endothelial markers and homocysteine in patients with classic Fabry disease","volume":"91","author":"Demuth","year":"2007","journal-title":"Acta Paediatr Suppl"},{"key":"2020122815000269200_sfaa227-B21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackerman","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"2020122815000269200_sfaa227-B22","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection\u00a0and endothelitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"2020122815000269200_sfaa227-B23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2020.07.008","article-title":"Impact of COVID-19 pandemic on patients with Fabry disease: an Italian experience","author":"Riccio","year":"2020","journal-title":"Mol Genet Metab"},{"key":"2020122815000269200_sfaa227-B24","doi-asserted-by":"crossref","first-page":"e009098","DOI":"10.1161\/JAHA.118.009098","article-title":"Elevated inflammatory plasma biomarkers in patients with Fabry disease: a critical link to heart failure with preserved ejection fraction","volume":"7","author":"Yogasundaram","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2020122815000269200_sfaa227-B25","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2020.04.006","article-title":"Collapsing glomerulopathy in a COVID-19 patient","author":"Kissling","year":"2020","journal-title":"Kidney Int"},{"key":"2020122815000269200_sfaa227-B26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol Genet Metab"},{"key":"2020122815000269200_sfaa227-B27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cns.12542","article-title":"Pain in Fabry disease: practical recommendations for diagnosis and treatment","volume":"22","author":"Politei","year":"2016","journal-title":"CNS Neurosci Ther"},{"key":"2020122815000269200_sfaa227-B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2020.100670","article-title":"Improvement of gastrointestinal symptoms in a significant proportion of male patients with classic Fabry disease treated with agalsidase beta: a Fabry Registry analysis stratified by phenotype","author":"Hopkin","year":"2020","journal-title":"Mol Genet Metab Report"},{"key":"2020122815000269200_sfaa227-B29","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","article-title":"Evidence for gastrointestinal infection of SARS-CoV-2","volume":"158","author":"Xiao","year":"2020","journal-title":"Gastroenterology"},{"key":"2020122815000269200_sfaa227-B30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gutjnl-2020-321013","article-title":"Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection","volume":"69","author":"Lin","year":"2020","journal-title":"Gut"},{"key":"2020122815000269200_sfaa227-B31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s004390050292","article-title":"Fluorescence-assisted mismatch analysis (FAMA) for exhaustive screening of the alpha-galactosidase A gene and detection of carriers in Fabry disease","volume":"98","author":"Germain","year":"1996","journal-title":"Hum Genet"},{"key":"2020122815000269200_sfaa227-B32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2016.06.007","article-title":"Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: data from the Fabry Registry","volume":"119","author":"Hopkin","year":"2016","journal-title":"Mol Genet Metab"},{"key":"2020122815000269200_sfaa227-B33","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"key":"2020122815000269200_sfaa227-B34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2020122815000269200_sfaa227-B35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1034\/j.1399-0004.2003.630107.x","article-title":"Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients","volume":"63","author":"Senechal","year":"2003","journal-title":"Clin Genet"},{"key":"2020122815000269200_sfaa227-B36","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjcard.2005.05.033","article-title":"Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease","volume":"96","author":"Shah","year":"2005","journal-title":"Am J Cardiol"},{"key":"2020122815000269200_sfaa227-B37","first-page":"1","article-title":"Update on coronary involvement in Fabry disease","volume":"4","author":"Cabrera","year":"2016","journal-title":"JIEMS"},{"key":"2020122815000269200_sfaa227-B38","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00134-020-06028-z","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"2020122815000269200_sfaa227-B39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ejhf.230","article-title":"Gender-specific plasma proteomic biomarkers in patients with Anderson-Fabry disease","volume":"17","author":"Hollander","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2020122815000269200_sfaa227-B40","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1073\/pnas.0611315104","article-title":"Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities","volume":"104","author":"Moore","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020122815000269200_sfaa227-B41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10545-013-9643-x","article-title":"Cognitive dysfunction and depression in Fabry disease: a systematic review","volume":"37","author":"Bolsover","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"2020122815000269200_sfaa227-B42","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","article-title":"Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy","volume":"23","author":"Ortiz","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2020122815000269200_sfaa227-B43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ndt\/gfp554","article-title":"End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry","volume":"25","author":"Ortiz","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2020122815000269200_sfaa227-B44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ckj\/sfaa119","article-title":"The keys to control a COVID-19 outbreak in a hemodialysis unit","volume":"13","author":"Rinc\u00f3n","year":"2020","journal-title":"Clin Kidney J"},{"key":"2020122815000269200_sfaa227-B45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ckj\/sfaa088","article-title":"Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients","volume":"13","author":"Couturier","year":"2020","journal-title":"Clin Kidney J"},{"key":"2020122815000269200_sfaa227-B46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/STROKEAHA.114.006283","article-title":"Cerebrovascular involvement in Fabry disease: current status of knowledge","volume":"46","author":"Kolodny","year":"2015","journal-title":"Stroke"},{"key":"2020122815000269200_sfaa227-B47","first-page":"1","article-title":"Lifting the mask on neurological manifestations of COVID-19","volume":"24","author":"Pezzini","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"2020122815000269200_sfaa227-B48","doi-asserted-by":"crossref","first-page":"110282","DOI":"10.1016\/j.mehy.2020.110282","article-title":"Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis","volume":"144","author":"Reisin","year":"2020","journal-title":"Med Hypotheses"},{"key":"2020122815000269200_sfaa227-B49","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/ene.14183","article-title":"Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology","volume":"27","author":"Mancuso","year":"2020","journal-title":"Eur J Neurol"},{"key":"2020122815000269200_sfaa227-B50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10545-009-9025-6","article-title":"Social-adaptive and psychological functioning of patients affected by Fabry disease","volume":"33","author":"Laney","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"2020122815000269200_sfaa227-B51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/8904_2017_21","article-title":"Treatment of depression in adults with Fabry disease","volume":"38","author":"Ali","year":"2018","journal-title":"JIMD Rep"},{"key":"2020122815000269200_sfaa227-B52","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2215-0366(20)30203-0","article-title":"Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic","volume":"7","author":"Rogers","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"2020122815000269200_sfaa227-B53","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"CoroNerve Study Group. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"2020122815000269200_sfaa227-B54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S2215-0366(20)30308-4","article-title":"Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population","volume":"7","author":"Pierce","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"2020122815000269200_sfaa227-B55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12889-020-08726-1","article-title":"Posttraumatic stress disorder and depression of survivors 12\u2009months after the outbreak of Middle East respiratory syndrome in South Korea","volume":"20","author":"Park","year":"2020","journal-title":"BMC Public Health"},{"key":"2020122815000269200_sfaa227-B56","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMc2011117","article-title":"Covid-19 and kidney transplantation","volume":"382","author":"Akalin","year":"2020","journal-title":"N Engl J Med"},{"key":"2020122815000269200_sfaa227-B57","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10545-007-0616-9","article-title":"Natural history of the respiratory involvement in Anderson-Fabry disease","volume":"30","author":"Magage","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"2020122815000269200_sfaa227-B58","doi-asserted-by":"crossref","first-page":"e0180437","DOI":"10.1371\/journal.pone.0180437","article-title":"Long-term follow-up of pulmonary function in Fabry disease: a bi-center observational study","volume":"12","author":"Franzen","year":"2017","journal-title":"PLoS One"},{"key":"2020122815000269200_sfaa227-B59","doi-asserted-by":"crossref","first-page":"e000277","DOI":"10.1136\/bmjresp-2018-000277","article-title":"Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy","volume":"5","author":"Franzen","year":"2018","journal-title":"BMJ Open Resp Res"},{"key":"2020122815000269200_sfaa227-B60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","article-title":"Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19","volume":"43","author":"Kai","year":"2020","journal-title":"Hypertens Res"},{"key":"2020122815000269200_sfaa227-B61","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"key":"2020122815000269200_sfaa227-B62","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"2020122815000269200_sfaa227-B63","year":"2020"},{"key":"2020122815000269200_sfaa227-B64","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMc2021225","article-title":"Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19","volume":"382","author":"Mehra","year":"2020","journal-title":"N Engl J Med"},{"key":"2020122815000269200_sfaa227-B65","doi-asserted-by":"crossref","first-page":"e25065","DOI":"10.1371\/journal.pone.0025065","article-title":"Receptor-mediated endocytosis of alpha-galactosidase A in human podocytes in Fabry disease","volume":"6","author":"Prabakaran","year":"2011","journal-title":"PLoS One"},{"key":"2020122815000269200_sfaa227-B66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.72.121801.161800","article-title":"Signals for sorting of transmembrane proteins to endosomes and lysosomes","volume":"72","author":"Bonifacino","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"2020122815000269200_sfaa227-B67","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020122815000269200_sfaa227-B68","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fmed.2020.00199","article-title":"Diabetic kidney disease and COVID-19: the crash of two pandemics","volume":"7","author":"D'Marco","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2020122815000269200_sfaa227-B69","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/FJC.0000000000000836","article-title":"Cardiovascular considerations in treating patients with Coronavirus Disease 2019 (COVID-19)","volume":"75","author":"Dixon","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"2020122815000269200_sfaa227-B70","author":"Beigel","year":"2020"},{"key":"2020122815000269200_sfaa227-B71"},{"key":"2020122815000269200_sfaa227-B72","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"2020122815000269200_sfaa227-B73","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [published online ahead of print","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2020122815000269200_sfaa227-B74","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"Molina","year":"2020","journal-title":"Med Mal Infect"},{"key":"2020122815000269200_sfaa227-B75"},{"key":"2020122815000269200_sfaa227-B76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fcvm.2016.00007","article-title":"Electrocardiographic changes and arrhythmia in Fabry disease","volume":"3","author":"Namdar","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"2020122815000269200_sfaa227-B77","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2020.05.014","article-title":"QT interval prolongation and Torsade De Pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin [published online ahead of print May 11, 2020]","volume":"17","author":"Chorin","year":"2020","journal-title":"Heart Rhythm"},{"key":"2020122815000269200_sfaa227-B78","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.34172\/jnp.2020.36","article-title":"SARS-CoV-2 and Fabry nephropathy: potential risks and the pathophysiological perspective","volume":"9","author":"Trimarchi","year":"2020","journal-title":"J Nephropathol"},{"key":"2020122815000269200_sfaa227-B79","doi-asserted-by":"crossref","first-page":"410","DOI":"10.34067\/KID.0002152020","article-title":"Peritoneal dialysis for acute kidney injury treatment in the United States: brought to you by the COVID-19 pandemic","volume":"1","author":"Srivatana","year":"2020","journal-title":"Kidney 360"},{"key":"2020122815000269200_sfaa227-B80","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.3346\/jkms.2020.35.e149","article-title":"Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea","volume":"35","author":"Ahn","year":"2020","journal-title":"J Korean Med Sci"},{"key":"2020122815000269200_sfaa227-B81"},{"key":"2020122815000269200_sfaa227-B82","first-page":"10045490","article-title":"The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts","volume":"19","author":"Germain","year":"2019","journal-title":"Mol Genet Metab Reports"},{"key":"2020122815000269200_sfaa227-B83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2018.06.004","article-title":"European expert consensus statement on therapeutic goals in Fabry disease","volume":"124","author":"Wanner","year":"2018","journal-title":"Mol Genet Metab"},{"key":"2020122815000269200_sfaa227-B84","year":"2020"},{"key":"2020122815000269200_sfaa227-B85","doi-asserted-by":"crossref","first-page":"105730","DOI":"10.1016\/j.envint.2020.105730","article-title":"Airborne transmission of SARS-CoV-2: the world should face the reality","volume":"139","author":"Morawska","year":"2020","journal-title":"Environ Int"},{"key":"2020122815000269200_sfaa227-B86","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymgme.2020.06.002","article-title":"Fabry disease during the COVID-19 pandemic. Why and how treatment should be continued","volume":"130","author":"Politei","year":"2020","journal-title":"Mol Genet Metab"},{"key":"2020122815000269200_sfaa227-B87","article-title":"Widespread covid-19 infection among Spanish healthcare professionals did not occur by chance","author":"Crespo","year":"2020","journal-title":"BMJ"},{"key":"2020122815000269200_sfaa227-B88"},{"key":"2020122815000269200_sfaa227-B89","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2666-5247(20)30003-3","article-title":"Stability of SARS-CoV-2 in different environmental conditions","volume":"1","author":"Chin","year":"2020","journal-title":"Lancet Microbe"},{"key":"2020122815000269200_sfaa227-B90","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13578-020-00404-4","article-title":"SARS-CoV-2 and COVID-19: the most important research questions","volume":"10","author":"Yuen","year":"2020","journal-title":"Cell Biosci"},{"key":"2020122815000269200_sfaa227-B91","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","article-title":"Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility","volume":"382","author":"Arons","year":"2020","journal-title":"N Engl J Med"},{"key":"2020122815000269200_sfaa227-B92","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10897-007-9128-x","article-title":"Diagnosis of Fabry disease via analysis of family history","volume":"17","author":"Laney","year":"2008","journal-title":"J Genet Counsel"},{"key":"2020122815000269200_sfaa227-B93","doi-asserted-by":"crossref","first-page":"e002794","DOI":"10.1136\/bmjgh-2020-002794","article-title":"Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China","volume":"5","author":"Wang","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2020122815000269200_sfaa227-B94","first-page":"334","article-title":"SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience","volume":"13","author":"Fontana","year":"2020","journal-title":"Clin Kidney J"},{"key":"2020122815000269200_sfaa227-B95","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"2020122815000269200_sfaa227-B96","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","article-title":"Genomewide association study of severe Covid-19 with respiratory failure","volume":"383","author":"Ellinghaus","year":"2020","journal-title":"N Engl J Med"},{"key":"2020122815000269200_sfaa227-B97","doi-asserted-by":"publisher","author":"Stawiski","year":"2020","DOI":"10.1101\/2020.04.07.024752);"},{"key":"2020122815000269200_sfaa227-B98","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1096\/fj.202000654R","article-title":"The lysosome: a potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications","volume":"34","author":"Ballout","year":"2020","journal-title":"FASEB J"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/13\/6\/913\/35204678\/sfaa227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/13\/6\/913\/35204678\/sfaa227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T20:01:28Z","timestamp":1609185688000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/13\/6\/913\/6054307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":98,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,12,24]]},"published-print":{"date-parts":[[2020,12,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaa227","relation":{},"ISSN":["2048-8513"],"issn-type":[{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,12]]}}}